POZEN Forgets Migraines to Collaborate with AstraZeneca
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 75 (Table of Contents)
Published: 1 Sep-2006
DOI: 10.3833/pdr.v2006.i75.457 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
The turbulent history and current potential are examined of POZEN, a North Carolina-based pharmaceutical company, whose fortunes took a turn for the positive at the beginning of August 2006 when it turned away from its migraine drugs, unsuccessful to date, to enter into a global collaboration agreement with AstraZeneca...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS